精神科用薬剤の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Psychiatric Medications Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16473 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・治療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、精神科用薬剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。精神科用薬剤の種類別市場規模（抗うつ薬、抗不安薬、気分安定薬、抗精神病薬）、用途別市場規模（病院、クリニック、家庭、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Abbott Laboratories、GlaxoSmithKline、AstraZeneca、H. Lundbeck、Eli Lilly and Company、Gedeon Richter、Novartis、Johnson & Johnson、Otsuka Pharmaceutical、Lupin Pharmaceuticals、Luye Pharma、SK Biopharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・精神科用薬剤の北米市場（アメリカ、カナダ、メキシコ） ・精神科用薬剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・精神科用薬剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・精神科用薬剤の南米市場（ブラジル、アルゼンチン） ・精神科用薬剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗うつ薬、抗不安薬、気分安定薬、抗精神病薬 ・用途別分析：病院、クリニック、家庭、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Psychiatric Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Psychiatric Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Psychiatric Medications market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Psychiatric Medications market has been segmented into:
Antidepressants
Anti-anxiety Medications
Mood-stabilizing Medications
Antipsychotic Medications

By Application, Psychiatric Medications has been segmented into:
Hospital Use
Clinic Use
Household

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Psychiatric Medications market presented in the report. This section sheds light on the sales growth of different regional and country-level Psychiatric Medications markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Psychiatric Medications market.

The report offers in-depth assessment of the growth and other aspects of the Psychiatric Medications market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Psychiatric Medications Market Share Analysis
Psychiatric Medications competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Psychiatric Medications sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Psychiatric Medications sales, revenue and market share for each player covered in this report.

The major players covered in Psychiatric Medications are:
Pfizer
Abbott Laboratories
GlaxoSmithKline
AstraZeneca
H. Lundbeck
Eli Lilly and Company
Gedeon Richter
Novartis
Johnson & Johnson
Otsuka Pharmaceutical
Lupin Pharmaceuticals
Luye Pharma
SK Biopharmaceuticals

レポート目次

---

Table of Contents

1 Psychiatric Medications Market Overview
1.1 Product Overview and Scope of Psychiatric Medications
1.2 Classification of Psychiatric Medications by Type
1.2.1 Global Psychiatric Medications Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Psychiatric Medications Revenue Market Share by Type in 2019
1.2.3 Antidepressants
1.2.4 Anti-anxiety Medications
1.2.5 Mood-stabilizing Medications
1.2.6 Antipsychotic Medications
1.3 Global Psychiatric Medications Market by Application
1.3.1 Overview: Global Psychiatric Medications Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.4 Global Psychiatric Medications Market by Regions
1.4.1 Global Psychiatric Medications Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Psychiatric Medications (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Psychiatric Medications Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Psychiatric Medications Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Psychiatric Medications Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Psychiatric Medications Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Psychiatric Medications Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Abbott Laboratories SWOT Analysis
2.2.4 Abbott Laboratories Product and Services
2.2.5 Abbott Laboratories Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline SWOT Analysis
2.3.4 GlaxoSmithKline Product and Services
2.3.5 GlaxoSmithKline Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.5 H. Lundbeck
2.5.1 H. Lundbeck Details
2.5.2 H. Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 H. Lundbeck SWOT Analysis
2.5.4 H. Lundbeck Product and Services
2.5.5 H. Lundbeck Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly and Company SWOT Analysis
2.6.4 Eli Lilly and Company Product and Services
2.6.5 Eli Lilly and Company Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.7 Gedeon Richter
2.7.1 Gedeon Richter Details
2.7.2 Gedeon Richter Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Gedeon Richter SWOT Analysis
2.7.4 Gedeon Richter Product and Services
2.7.5 Gedeon Richter Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.10 Otsuka Pharmaceutical
2.10.1 Otsuka Pharmaceutical Details
2.10.2 Otsuka Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Otsuka Pharmaceutical SWOT Analysis
2.10.4 Otsuka Pharmaceutical Product and Services
2.10.5 Otsuka Pharmaceutical Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.11 Lupin Pharmaceuticals
2.11.1 Lupin Pharmaceuticals Details
2.11.2 Lupin Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Lupin Pharmaceuticals SWOT Analysis
2.11.4 Lupin Pharmaceuticals Product and Services
2.11.5 Lupin Pharmaceuticals Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.12 Luye Pharma
2.12.1 Luye Pharma Details
2.12.2 Luye Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Luye Pharma SWOT Analysis
2.12.4 Luye Pharma Product and Services
2.12.5 Luye Pharma Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
2.13 SK Biopharmaceuticals
2.13.1 SK Biopharmaceuticals Details
2.13.2 SK Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 SK Biopharmaceuticals SWOT Analysis
2.13.4 SK Biopharmaceuticals Product and Services
2.13.5 SK Biopharmaceuticals Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Psychiatric Medications Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Psychiatric Medications Players Market Share
3.2.2 Top 10 Psychiatric Medications Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Psychiatric Medications Revenue and Market Share by Regions
4.2 North America Psychiatric Medications Revenue and Growth Rate (2015-2020)
4.3 Europe Psychiatric Medications Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Psychiatric Medications Revenue and Growth Rate (2015-2020)
4.5 South America Psychiatric Medications Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Psychiatric Medications Revenue and Growth Rate (2015-2020)
5 North America Psychiatric Medications Revenue by Countries
5.1 North America Psychiatric Medications Revenue by Countries (2015-2020)
5.2 USA Psychiatric Medications Revenue and Growth Rate (2015-2020)
5.3 Canada Psychiatric Medications Revenue and Growth Rate (2015-2020)
5.4 Mexico Psychiatric Medications Revenue and Growth Rate (2015-2020)
6 Europe Psychiatric Medications Revenue by Countries
6.1 Europe Psychiatric Medications Revenue by Countries (2015-2020)
6.2 Germany Psychiatric Medications Revenue and Growth Rate (2015-2020)
6.3 UK Psychiatric Medications Revenue and Growth Rate (2015-2020)
6.4 France Psychiatric Medications Revenue and Growth Rate (2015-2020)
6.5 Russia Psychiatric Medications Revenue and Growth Rate (2015-2020)
6.6 Italy Psychiatric Medications Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Psychiatric Medications Revenue by Countries
7.1 Asia-Pacific Psychiatric Medications Revenue by Countries (2015-2020)
7.2 China Psychiatric Medications Revenue and Growth Rate (2015-2020)
7.3 Japan Psychiatric Medications Revenue and Growth Rate (2015-2020)
7.4 Korea Psychiatric Medications Revenue and Growth Rate (2015-2020)
7.5 India Psychiatric Medications Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Psychiatric Medications Revenue and Growth Rate (2015-2020)
8 South America Psychiatric Medications Revenue by Countries
8.1 South America Psychiatric Medications Revenue by Countries (2015-2020)
8.2 Brazil Psychiatric Medications Revenue and Growth Rate (2015-2020)
8.3 Argentina Psychiatric Medications Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Psychiatric Medications by Countries
9.1 Middle East & Africa Psychiatric Medications Revenue by Countries (2015-2020)
9.2 Saudi Arabia Psychiatric Medications Revenue and Growth Rate (2015-2020)
9.3 UAE Psychiatric Medications Revenue and Growth Rate (2015-2020)
9.4 Egypt Psychiatric Medications Revenue and Growth Rate (2015-2020)
9.5 South Africa Psychiatric Medications Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Psychiatric Medications Revenue and Market Share by Type (2015-2020)
10.2 Global Psychiatric Medications Market Forecast by Type (2019-2024)
10.3 Antidepressants Revenue Growth Rate (2015-2025)
10.4 Anti-anxiety Medications Revenue Growth Rate (2015-2025)
10.5 Mood-stabilizing Medications Revenue Growth Rate (2015-2025)
10.6 Antipsychotic Medications Revenue Growth Rate (2015-2025)
11 Global Psychiatric Medications Market Segment by Application
11.1 Global Psychiatric Medications Revenue Market Share by Application (2015-2020)
11.2 Psychiatric Medications Market Forecast by Application (2019-2024)
11.3 Hospital Use Revenue Growth (2015-2020)
11.4 Clinic Use Revenue Growth (2015-2020)
11.5 Household Revenue Growth (2015-2020)
12 Global Psychiatric Medications Market Size Forecast (2021-2025)
12.1 Global Psychiatric Medications Market Size Forecast (2021-2025)
12.2 Global Psychiatric Medications Market Forecast by Regions (2021-2025)
12.3 North America Psychiatric Medications Revenue Market Forecast (2021-2025)
12.4 Europe Psychiatric Medications Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Psychiatric Medications Revenue Market Forecast (2021-2025)
12.6 South America Psychiatric Medications Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Psychiatric Medications Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Psychiatric Medications Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Psychiatric Medications by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Psychiatric Medications Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Psychiatric Medications Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Psychiatric Medications Major Business
Table 7. Pfizer Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Psychiatric Medications Product and Solutions
Table 10. Pfizer Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Abbott Laboratories Corporate Information, Location and Competitors
Table 12. Abbott Laboratories Psychiatric Medications Major Business
Table 13. Abbott Laboratories Psychiatric Medications Total Revenue (USD Million) (2018-2019)
Table 14. Abbott Laboratories SWOT Analysis
Table 15. Abbott Laboratories Psychiatric Medications Product and Solutions
Table 16. Abbott Laboratories Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GlaxoSmithKline Corporate Information, Location and Competitors
Table 18. GlaxoSmithKline Psychiatric Medications Major Business
Table 19. GlaxoSmithKline Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 20. GlaxoSmithKline SWOT Analysis
Table 21. GlaxoSmithKline Psychiatric Medications Product and Solutions
Table 22. GlaxoSmithKline Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AstraZeneca Corporate Information, Location and Competitors
Table 24. AstraZeneca Psychiatric Medications Major Business
Table 25. AstraZeneca Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 26. AstraZeneca SWOT Analysis
Table 27. AstraZeneca Psychiatric Medications Product and Solutions
Table 28. AstraZeneca Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. H. Lundbeck Corporate Information, Location and Competitors
Table 30. H. Lundbeck Psychiatric Medications Major Business
Table 31. H. Lundbeck Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 32. H. Lundbeck SWOT Analysis
Table 33. H. Lundbeck Psychiatric Medications Product and Solutions
Table 34. H. Lundbeck Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Eli Lilly and Company Corporate Information, Location and Competitors
Table 36. Eli Lilly and Company Psychiatric Medications Major Business
Table 37. Eli Lilly and Company Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 38. Eli Lilly and Company SWOT Analysis
Table 39. Eli Lilly and Company Psychiatric Medications Product and Solutions
Table 40. Eli Lilly and Company Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Gedeon Richter Corporate Information, Location and Competitors
Table 42. Gedeon Richter Psychiatric Medications Major Business
Table 43. Gedeon Richter Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 44. Gedeon Richter SWOT Analysis
Table 45. Gedeon Richter Psychiatric Medications Product and Solutions
Table 46. Gedeon Richter Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Novartis Corporate Information, Location and Competitors
Table 48. Novartis Psychiatric Medications Major Business
Table 49. Novartis Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 50. Novartis SWOT Analysis
Table 51. Novartis Psychiatric Medications Product and Solutions
Table 52. Novartis Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Johnson & Johnson Corporate Information, Location and Competitors
Table 54. Johnson & Johnson Psychiatric Medications Major Business
Table 55. Johnson & Johnson Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 56. Johnson & Johnson SWOT Analysis
Table 57. Johnson & Johnson Psychiatric Medications Product and Solutions
Table 58. Johnson & Johnson Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Otsuka Pharmaceutical Corporate Information, Location and Competitors
Table 60. Otsuka Pharmaceutical Psychiatric Medications Major Business
Table 61. Otsuka Pharmaceutical Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 62. Otsuka Pharmaceutical SWOT Analysis
Table 63. Otsuka Pharmaceutical Psychiatric Medications Product and Solutions
Table 64. Otsuka Pharmaceutical Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Lupin Pharmaceuticals Corporate Information, Location and Competitors
Table 66. Lupin Pharmaceuticals Psychiatric Medications Major Business
Table 67. Lupin Pharmaceuticals Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 68. Lupin Pharmaceuticals SWOT Analysis
Table 69. Lupin Pharmaceuticals Psychiatric Medications Product and Solutions
Table 70. Lupin Pharmaceuticals Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Luye Pharma Corporate Information, Location and Competitors
Table 72. Luye Pharma Psychiatric Medications Major Business
Table 73. Luye Pharma Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 74. Luye Pharma SWOT Analysis
Table 75. Luye Pharma Psychiatric Medications Product and Solutions
Table 76. Luye Pharma Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. SK Biopharmaceuticals Corporate Information, Location and Competitors
Table 78. SK Biopharmaceuticals Psychiatric Medications Major Business
Table 79. SK Biopharmaceuticals Psychiatric Medications Total Revenue (USD Million) (2017-2018)
Table 80. SK Biopharmaceuticals SWOT Analysis
Table 81. SK Biopharmaceuticals Psychiatric Medications Product and Solutions
Table 82. SK Biopharmaceuticals Psychiatric Medications Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Psychiatric Medications Revenue (Million USD) by Players (2015-2020)
Table 84. Global Psychiatric Medications Revenue Share by Players (2015-2020)
Table 85. Global Psychiatric Medications Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Psychiatric Medications Revenue Market Share by Regions (2015-2020)
Table 87. North America Psychiatric Medications Revenue by Countries (2015-2020)
Table 88. North America Psychiatric Medications Revenue Market Share by Countries (2015-2020)
Table 89. Europe Psychiatric Medications Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Psychiatric Medications Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Psychiatric Medications Revenue by Countries (2015-2020)
Table 92. South America Psychiatric Medications Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Psychiatric Medications Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Psychiatric Medications Revenue Market Share by Countries (2015-2020)
Table 95. Global Psychiatric Medications Revenue (Million USD) by Type (2015-2020)
Table 96. Global Psychiatric Medications Revenue Share by Type (2015-2020)
Table 97. Global Psychiatric Medications Revenue Forecast by Type (2021-2025)
Table 98. Global Psychiatric Medications Revenue by Application (2015-2020)
Table 99. Global Psychiatric Medications Revenue Share by Application (2015-2020)
Table 100. Global Psychiatric Medications Revenue Forecast by Application (2021-2025)
Table 101. Global Psychiatric Medications Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Psychiatric Medications Picture
Figure 2. Global Psychiatric Medications Revenue Market Share by Type in 2019
Figure 3. Antidepressants Picture
Figure 4. Anti-anxiety Medications Picture
Figure 5. Mood-stabilizing Medications Picture
Figure 6. Antipsychotic Medications Picture
Figure 7. Psychiatric Medications Revenue Market Share by Application in 2019
Figure 8. Hospital Use Picture
Figure 9. Clinic Use Picture
Figure 10. Household Picture
Figure 11. Global Psychiatric Medications Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Psychiatric Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Psychiatric Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Psychiatric Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Psychiatric Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Psychiatric Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Psychiatric Medications Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Psychiatric Medications Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Psychiatric Medications Revenue Market Share in 2019
Figure 20. Global Top 10 Players Psychiatric Medications Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Psychiatric Medications Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Psychiatric Medications Revenue Market Share by Regions (2015-2020)
Figure 24. Global Psychiatric Medications Revenue Market Share by Regions in 2018
Figure 25. North America Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 26. Europe Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 28. South America Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 30. North America Psychiatric Medications Revenue Market Share by Countries (2015-2020)
Figure 31. North America Psychiatric Medications Revenue Market Share by Countries in 2019
Figure 32. USA Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 33. Canada Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 35. Europe Psychiatric Medications Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Psychiatric Medications Revenue Market Share by Countries in 2019
Figure 37. Germany Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 38. UK Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 39. France Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 40. Russia Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 41. Italy Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Psychiatric Medications Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Psychiatric Medications Revenue Market Share by Countries in 2019
Figure 44. China Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 45. Japan Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 46. Korea Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 47. India Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 49. South America Psychiatric Medications Revenue Market Share by Countries (2015-2020)
Figure 50. South America Psychiatric Medications Revenue Market Share by Countries in 2019
Figure 51. Brazil Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Psychiatric Medications Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Psychiatric Medications Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 56. UAE Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Psychiatric Medications Revenue and Growth Rate (2015-2020)
Figure 59. Global Psychiatric Medications Revenue Share by Type (2015-2020)
Figure 60. Global Psychiatric Medications Revenue Share by Type in 2019
Figure 61. Global Psychiatric Medications Market Share Forecast by Type (2021-2025)
Figure 62. Global Antidepressants Revenue Growth Rate (2015-2020)
Figure 63. Global Anti-anxiety Medications Revenue Growth Rate (2015-2020)
Figure 64. Global Mood-stabilizing Medications Revenue Growth Rate (2015-2020)
Figure 65. Global Antipsychotic Medications Revenue Growth Rate (2015-2020)
Figure 66. Global Psychiatric Medications Revenue Share by Application (2015-2020)
Figure 67. Global Psychiatric Medications Revenue Share by Application in 2019
Figure 68. Global Psychiatric Medications Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Use Revenue Growth Rate (2015-2020)
Figure 70. Global Clinic Use Revenue Growth Rate (2015-2020)
Figure 71. Global Household Revenue Growth Rate (2015-2020)
Figure 72. Global Psychiatric Medications Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Psychiatric Medications Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Psychiatric Medications Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Psychiatric Medications Revenue Market Forecast (2021-2025)
Figure 76. Europe Psychiatric Medications Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Psychiatric Medications Revenue Market Forecast (2021-2025)
Figure 78. South America Psychiatric Medications Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Psychiatric Medications Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---